MENU
CARA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cara Therapeutics (CARA) Ownership - Who owns Cara Therapeutics?
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
400 Atlantic Street
Phone
+1 203 406-3700
Employees
55
Web
https://www.caratherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.43M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
3.42M
Revenue
8.69M
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
1.56 USD as % of share price
Fundamentals
CARA
Capitalization
23.4M
P/E Ratio
N/A
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
3.42M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.56%
Revenue
8.69M
ROE
N/A
Book Value
707K
P/B Ratio
33.11
Cash Flow
N/A
Earnings
-21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
4.77
Current Revenue Per Employee
46472.73
Dividends Per Share - Security
N/A
EBITDA
-88.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-114.63
Shares Held By Institutions
5.43M
Shares Outstanding - Current
4.57M
Total Liabilities
50.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
-16.258
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Atlantic Street
Phone
+1 203 406-3700
Employees
55
Web
https://www.caratherapeutics.com